Literature DB >> 8859284

A multirater validation study to assess the reliability of acne lesion counting.

A W Lucky1, B L Barber, C J Girman, J Williams, J Ratterman, J Waldstreicher.   

Abstract

BACKGROUND: Despite widespread use of acne lesion counting, little has been published on its reliability, particularly for multiple raters.
OBJECTIVE: Our purpose was to assess reliability of acne lesion counting with the use of a five-segment facial template.
METHODS: After training, 12 raters each evaluated 12 patients in randomized order, in the morning and again in the afternoon, and recorded counts for different types of lesions on a five-segment facial template.
RESULTS: Individual raters could reproduce their total lesion counts (reliability estimates, 0.81 to 0.97). Variability between raters was high, and overall reliability estimated across raters was 0.61. For a subgroup of commonly trained raters, overall reliability was higher (0.80).
CONCLUSION: The reliability of acne lesion counting is excellent when performed by the same trained rater over time. The high variability between raters appears to be reduced by standardized training. Because fewer lesions are counted with less variation, use of a template may have contributed to the high within-rater reliability.

Entities:  

Mesh:

Year:  1996        PMID: 8859284     DOI: 10.1016/s0190-9622(96)90680-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  14 in total

1.  Three-dimensional, Full-sized, Silicone-based, Facial Replicas for Teaching Outcome Measures in Acne.

Authors:  Jerry K L Tan; Jing Tang
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

2.  Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.

Authors:  J S Kirby; M Butt; T King
Journal:  Br J Dermatol       Date:  2019-08-27       Impact factor: 9.302

3.  The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus.

Authors:  Joerg Albrecht; Lynne Taylor; Jesse A Berlin; Samuel Dulay; Gina Ang; Steven Fakharzadeh; Jonathan Kantor; Ellen Kim; Giuseppe Militello; Karen McGinnis; Stephen Richardson; James Treat; Carmela Vittorio; Abby Van Voorhees; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2005-11       Impact factor: 8.551

4.  Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.

Authors:  Rachel S Klein; Pamela A Morganroth; Victoria P Werth
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 5.  A Comprehensive Critique and Review of Published Measures of Acne Severity.

Authors:  Tamara Agnew; Gareth Furber; Matthew Leach; Leonie Segal
Journal:  J Clin Aesthet Dermatol       Date:  2016-07-01

6.  Escalating weekly doses of cetuximab and correlation with skin toxicity: a phase I study.

Authors:  Cheryl Ho; Randeep Sangha; Laurel Beckett; Michael Tanaka; Derick H Lau; Daniel B Eisen; Rachel A Burich; Paul Luciw; Imran Khan; Philip C Mack; David R Gandara; Angela M Davies
Journal:  Invest New Drugs       Date:  2010-02-12       Impact factor: 3.850

Review 7.  Clinical outcome measures for cutaneous lupus erythematosus.

Authors:  J Albrecht; V P Werth
Journal:  Lupus       Date:  2010-08       Impact factor: 2.911

Review 8.  Development of outcome measures for autoimmune dermatoses.

Authors:  Elizabeth Gaines; Victoria P Werth
Journal:  Arch Dermatol Res       Date:  2007-11-06       Impact factor: 3.017

9.  Acne and PCOS are less frequent in women with Mayer-Rokitansky-Küster-Hauser syndrome despite a high rate of hyperandrogenemia: a cross-sectional study.

Authors:  Katharina Rall; Gabriele Conzelmann; Norbert Schäffeler; Melanie Henes; Diethelm Wallwiener; Matthias Möhrle; Sara Y Brucker
Journal:  Reprod Biol Endocrinol       Date:  2014-03-18       Impact factor: 5.211

10.  Global clinical response in Cushing's syndrome patients treated with mifepristone.

Authors:  Laurence Katznelson; D Lynn Loriaux; David Feldman; Glenn D Braunstein; David E Schteingart; Coleman Gross
Journal:  Clin Endocrinol (Oxf)       Date:  2013-10-17       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.